Pharmaceutical

Innate shelves lacutamab monotherapy plans in peripheral T cell lymphoma

A combo trial will continue as planned in addition to the biotech’s cutaneous T Cell lymphoma programme.

Mar 24, 2024 - 00:00
Innate shelves lacutamab monotherapy plans in peripheral T cell lymphoma
A combo trial will continue as planned in addition to the biotech’s cutaneous T Cell lymphoma programme.
Read the original article

Tags:

Previous Article

Pharmaceutical consulting companies, pharmaceutical training and other developme...

Next Article

Chinook Therapeutics files patent for improving kidney function in a subject

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Morgan Health wants you to know it’s still here

STAT+: Morgan Health wants you to know it’s still here

Jan 10, 2024

STAT+: Pharmalittle: We’re reading about GLP-1 drugs’ safety, Novartis nixing a deal, and more

STAT+: Pharmalittle: We’re reading about GLP-1 drugs’ s...

Jan 12, 2024

Verix boosts life science AI capabilities with start-up.ai acquisition

Verix boosts life science AI capabilities with start-up...

Jun 17, 2023